News

CIRC Trial Results to be Presented at ReSS ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced that 27 scientific presentations related to ZOLL products and technology are scheduled to be...

Campaign Empowers People With a Slow Heartbeat to Learn About Treatment Options and How to Have an Informed Discussion With Their Doctor Famed dancer, actress, and director Debbie Allen has teamed up with Medtronic, Inc. to kick off "Join...

EP Thought Leaders to Discuss Advances in Catheter Ablation CardioFocus, Inc., developer of the HeartLight™ Endoscopic Ablation System (EAS) for the treatment of atrial fibrillation (AF), announces that its HeartLight EAS will be discussed...

Prophylactic Use of Impella Achieves Cost-Effective Threshold Abiomed, Inc., a leading provider of breakthrough heart support technologies, announced results of an economic study at the annual 2011 Transcatheter Cardiovascular Therapeutics...

Stereotaxis Partners with NACCME's Cardiovascular Learning Network® to Deliver Live Broadcasts for Online Medical Education Stereotaxis, Inc. announced the launch of Odyssey Cinema™ Studio, an industry-first clinical procedure online...

A new study indicates strong diagnostic ability of treadmill exercise stress testing to uncover Long QT syndrome (LQTS) in patients. Here, investigators from the Mayo Clinic show how the recovery phase displays significant and maladaptive...

ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced that it will display the LifeVest® Wearable Defibrillator, the AutoPulse® Non-invasive Cardiac Support Pump, and the ZOLL Intravascular...

nContact, Inc., the leading innovator in epicardial ablation devices, announced the launch of its new corporate websites, www.ncontactinc.eu and www.ncontactinc.com. The design of the new corporate sites reflects the evolution of nContact’s...

ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced that more than 50,000 patients at high risk of sudden cardiac arrest (SCA) have been prescribed the LifeVest® Wearable Defibrillator. The...

Medtronic, Inc. announced that the U.S. Food and Drug Administration’s (FDA) Circulatory Systems Devices advisory panel voted against the Medtronic Phased RF Ablation System, the first atrial fibrillation ablation therapy under investigation...